Detalhe da pesquisa
1.
Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.
Hematol Oncol
; 36(2): 495-497, 2018 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-28664979